Evidence map›Paper›PMID 40710328›Full record

ReviewCells2025

Converging Molecular Mechanisms of Nucleated Cell Death Pathways and Procoagulant Platelet Formation.

Cong Li, Attila Braun, Juan Zu, Thomas Gudermann, Elmina Mammadova-Bach, Hans-Joachim Anders

Abstract readReview
In one paragraph

Review in Cells, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Toward targeting of inflammasome signaling in venous thrombosis.Journal of thrombosis and haemostasis : JTH · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Cong LiDivision of Nephrology, Department of Medicine IV, Ludwig Maximilian University Hospital, 80336 Munich, Germany.ORCID 0000-0002-0683-4159
Attila BraunWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University, 80336 Munich, Germany.
Juan ZuCenter for Neuropathology, Ludwig Maximilian University, 81377 Munich, Germany.
Thomas GudermannWalther Straub Institute of Pharmacology and Toxicology, Ludwig Maximilian University, 80336 Munich, Germany.
Elmina Mammadova-BachDivision of Nephrology, Department of Medicine IV, Ludwig Maximilian University Hospital, 80336 Munich, Germany.
Hans-Joachim AndersDivision of Nephrology, Department of Medicine IV, Ludwig Maximilian University Hospital, 80336 Munich, Germany.ORCID 0000-0003-2434-2956

Funding

DFG AN372/20-3, no 273724288, and TRR332 project A7DFG CRC TRR152LGL BLGL: project number 15-25
6 · The paper itself

Abstract

Procoagulant platelets are a specialized subset of activated platelets that externalize phosphatidylserine (PS) on their surface, facilitating the assembly of tenase and prothrombinase complexes and enhancing thrombin generation and clot formation. Although procoagulant platelet formation shares certain features with nucleated cell death pathways, such as mitochondrial dysfunction, calcium (Ca

Indexed as

Blood CoagulationBlood PlateletsCell DeathAnimalsHumansNecroptosisPlatelet ActivationThrombosisapoptosiscell deathcoagulationferroptosisnecroptosisnecrosisplatelet procoagulant activitypyroptosisthrombosis

Identifiers

PMID40710328
PMCPMC12293194

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.